- FY2026 guidance raised: Revenue to $1.44B–$1.46B and Adj. EBITDA to $136M–$138M (prior: $129M–$131M)
- Residents served increased 7% YoY to approximately 218,000
- Q3 net income and EPS showed substantial expansion alongside increased cash balance
Why is $GRDN moving today? · SEC 8-K archive
$GRDN SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $GRDN: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $GRDN filing catalyst
Why did $GRDN trigger an AI stock catalyst alert?
$GRDN triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: Guardian Pharmacy Services Reports Q3 2026 Results, Raises FY26 Guidance. Key points: - FY2026 guidance raised: Revenue to $1.44B–$1.46B and Adj. EBITDA to $136M–$138M (prior: $129M–$131M) - Residents served increased 7% YoY to approximately 218,000 - Q3 net income and EPS showed substantial expansion alongside increased cash balance
How did $GRDN stock react after the SEC filing?
After the SEC 8-K for $GRDN, observed market reaction: T0 price $39.84. Past moves do not guarantee future results.
Where can I get real-time $GRDN SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $GRDN via Telegram and the VIP Web Terminal from €10/month.